InicioOPL • ASX
add
Opyl Ltd
Cierre anterior
0,015 $
Intervalo anual
0,014 $ - 0,035 $
Cap. bursátil
2,17 M AUD
Volumen medio
199,34 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
ASX
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (AUD) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos | 76,98 mil | -53,11 % |
Gastos operativos | 421,40 mil | 55,20 % |
Ingresos netos | -927,04 mil | -67,65 % |
Margen de beneficio neto | -1,20 mil | -257,51 % |
Beneficios por acción | — | — |
EBITDA | -909,06 mil | -66,48 % |
Tipo impositivo efectivo | — | — |
Balance general
Activos totales
Responsabilidades totales
| (AUD) | jun 2024info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 374,64 mil | -17,27 % |
Activos totales | 411,60 mil | -41,99 % |
Responsabilidades totales | 501,76 mil | -54,93 % |
Patrimonio total | -90,16 mil | — |
Acciones en circulación | 222,15 M | — |
Precio-valor contable | ∞ | — |
Rentabilidad económica | -556,44 % | — |
Retorno sobre capital | 2.540,24 % | — |
Flujo de caja
Variación neta del flujo de caja
| (AUD) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | -927,04 mil | -67,65 % |
Efectivo de operaciones | -738,29 mil | -58,54 % |
Efectivo de inversión | -8,86 mil | -7.807,14 % |
Efectivo de financiación | 642,12 mil | 72,83 % |
Variación neta del flujo de caja | -105,03 mil | -11,42 % |
Flujo de caja libre | -171,58 mil | 42,93 % |
Información sobre la empresa
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Fundación
2013
Sitio web
Empleados
3
